Terns Pharma Insider Trading Activity | NASDAQ:TERN

Terns Pharmaceuticals Inc Insider Trading Activity

TERNNASDAQ

Trade with Public

$52.88

-0.04-0.08%

At close: Mar 27, 5:00 PM EST

$52.75

-0.17-0.32%

Pre-Market: 5:28 AM EST

M&A: Terns Pharma (TERN) announced it will be acquired by Merck & Co (MRK) on Wednesday, March 25, 2026 for $6.7B paid in cash

Terns Pharma Insider Trading Activity | NASDAQ:TERN | Benzinga

Track the latest Terns Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for Terns Pharma stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Terns Pharmaceuticals Inc Insiders Doing?

At Terns Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.

Notable Recent Insider Buys and Sales

On January 6, 2026, Emil Kuriakose, the company's CHIEF MEDICAL OFFICER sold 1.16K shares for 38.57 each.

Ownership Statistics for Terns Pharmaceuticals Inc

Shares Outstanding

113.014M

Shares Float

112981267.0%

Insider Shares Owned

1.126M

Insider Percentage Owned

1.06%

Institutional Shares Held

43.356M

Institutional Percentage Held

39.9%

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

TERN Insider Trading News

$2.4 Million Bet On Duolingo? Check Out These 3 Stocks Insiders Are Buying

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Lisa Levin

$5.5 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying

Although US stocks closed higher on Friday, there were a few notable insider trades.

Lisa Levin

$2.2 Million Bet On Terns Pharmaceuticals? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Terns Pharmaceuticals Director Hongbo Lu Reported Purchase of 4,124,239 @ Avg Price of $2.57/Share in Form 4 Filing on Tuesday

Charles Gross

3 Stocks Under $2 Insiders Are Aggressively Buying

US crude oil futures traded higher this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

People Also Watch

Axsome Therapeutics Inc

NASDAQ:AXSM

$160.50

Ligand Pharmaceuticals Inc

NASDAQ:LGND

$192.64

Terns Pharma Insider Trading Activity | NASDAQ:TERN | Benzinga

Track the latest Terns Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for Terns Pharma stock.

What is Insider Activity?

What are Terns Pharmaceuticals Inc Insiders Doing?

Notable Recent Insider Buys and Sales

On January 6, 2026, Emil Kuriakose, the company's CHIEF MEDICAL OFFICER sold 1.16K shares for 38.57 each.


Mar 17, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	0.00	$25.67	-$613.44K	SELL-OPTIONS	0.00%	297.30K	Mar 16	View
Feb 18, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	0.00	$21.92	-$503.91K	SELL-OPTIONS	0.00%	297.30K	Feb 17	View
Jan 16, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	150.00K	$20.86	-$2.23M	SELL-OPTIONS	101.84%	297.30K	Jan 14 - Jan 15	View
Jan 06, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	100.21K	$21.37	-$2.62M	SELL-OPTIONS	212.84%	147.29K	Jan 02 - Jan 05	View
Jan 06, 2026	Emil Kuriakose	CHIEF MEDICAL OFFICER	-1.16K	$38.57	-$44.55K	SELL	-2.24%	50.37K	Jan 02	View
Nov 05, 2025	Jill M Quigley	—	0.00	$13.62	-$214.80K	SELL-OPTIONS	0.00%	0.00	Nov 04	View
Oct 02, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-944.00	$7.85	-$7.41K	SELL	-1.80%	51.52K	Oct 01	View
Jul 03, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-853.00	$4.27	-$3.64K	SELL	-1.60%	52.46K	Jul 01	View
Jun 30, 2025	Andrew Gengos	CHIEF FINANCIAL OFFICER	10.00K	$3.93	$39.28K	BUY	66.67%	25.00K	Jun 27	View
Jun 25, 2025	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	23.31K	$3.87	$90.23K	BUY	98.09%	47.08K	Jun 25	View
Jun 16, 2025	Andrew Gengos	CHIEF FINANCIAL OFFICER	15.00K	$3.81	$57.08K	BUY	∞	15.00K	Jun 13 - Jun 16	View
Apr 02, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-952.00	$2.49	-$2.37K	SELL	-1.75%	53.32K	Apr 01	View
Feb 03, 2025	Melita Sun Jung	CHIEF BUSINESS OFFICER	2.25K	$5.11	$11.50K	BUY	∞	2.25K	Nov 30	View
Feb 03, 2025	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	510.00	$5.11	$2.61K	BUY	2.67%	19.61K	Nov 30	View
Jan 06, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-4.48K	$5.71	-$25.61K	SELL	-7.63%	54.27K	Jan 02	View
Jan 06, 2025	Mark J Vignola	CHIEF FINANCIAL OFFICER	-17.19K	$5.76	-$99.02K	SELL	-18.69%	74.75K	Jan 02 - Jan 06	View
Jan 06, 2025	Jill M Quigley	—	-15.00K	$5.76	-$86.46K	SELL	-100.00%	0.00	Jan 02 - Jan 06	View
Dec 09, 2024	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	15.45K	$7.15	$110.47K	BUY	423.40%	19.10K	Dec 05	View
Sep 17, 2024	Hongbo Lu By: Hongbo Lu	DIRECTOR	476.19K	$10.50	$5.00M	BUY	∞	476.19K	Sep 12	View
Sep 12, 2024	Mark J Vignola	CHIEF FINANCIAL OFFICER	0.00	$8.18	-$56.40K	SELL-OPTIONS	0.00%	91.94K	Sep 10	View
Sep 11, 2024	Jill M Quigley	—	0.00	$5.91	-$140.98K	SELL-OPTIONS	0.00%	15.00K	Sep 09	View
Aug 05, 2024	Jill M Quigley	—	-15.00K	$7.57	-$113.58K	SELL	-50.00%	15.00K	Aug 01 - Aug 02	View
Jul 17, 2024	Carl L Gordon	DIRECTOR	-56.16K	$10.00	-$561.64K	SELL	-6.92%	755.63K	Jul 15 - Jul 16	View
Jul 17, 2024	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC	DIRECTOR	-56.16K	$10.00	-$561.64K	SELL	-6.92%	755.63K	Jul 15 - Jul 16	View
Jul 17, 2024	Jill M Quigley	—	0.00	$5.91	-$120.79K	SELL-OPTIONS	0.00%	30.00K	Jul 15 - Jul 16	View
Jun 04, 2024	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	4.79K	$4.44	$21.27K	BUY	5.50%	91.94K	May 31	View
Jun 04, 2024	Mark J Vignola	CHIEF FINANCIAL OFFICER	4.79K	$4.44	$21.27K	BUY	5.50%	91.94K	May 31	View
Apr 03, 2024	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	-420.66K	$6.65	-$2.80M	SELL	-61.03%	268.57K	Apr 01 - Apr 03	View
Dec 04, 2023	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	743.00	$3.78	$2.81K	BUY	4.21%	18.40K	Nov 30	View
Dec 04, 2023	Mark J Vignola	CHIEF FINANCIAL OFFICER	743.00	$3.78	$2.81K	BUY	4.21%	18.40K	Nov 30	View
Jun 02, 2023	Mark J Vignola	CHIEF FINANCIAL OFFICER	10.00K	$1.41	$14.10K	BUY	130.53%	17.66K	May 31	View
Jun 02, 2023	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	10.00K	$1.41	$14.10K	BUY	130.53%	17.66K	May 31	View
Jun 02, 2023	Senthil Sundaram	CHIEF EXECUTIVE OFFICER	2.11K	$1.41	$2.98K	BUY	27.56%	9.77K	May 31	View
Feb 03, 2023	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	3.00	$1.41	$4.23	BUY	0.04%	7.66K	Nov 30	View
Feb 03, 2023	Mark J Vignola	CHIEF FINANCIAL OFFICER	3.00	$1.41	$4.23	BUY	0.04%	7.66K	Nov 30	View
Feb 03, 2023	Senthil Sundaram	CHIEF EXECUTIVE OFFICER	3.00	$1.41	$4.23	BUY	0.04%	7.66K	Nov 30	View
Dec 28, 2022	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC	DIRECTOR	137.93K	$7.25	$1000.00K	BUY	2.50%	5.65M	Dec 23	View
Dec 28, 2022	Carl L Gordon	DIRECTOR	137.93K	$7.25	$1000.00K	BUY	2.50%	5.65M	Dec 23	View
Dec 23, 2022	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	758.62K	$7.25	$5.50M	BUY	19.64%	4.62M	Dec 23	View
Dec 23, 2022	Hongbo Lu	—	758.62K	$7.25	$5.50M	BUY	21.18%	4.34M	Dec 23	View
Nov 28, 2022	LAV Biosciences Fund V LP Hopewell Resources Holdings Ltd LAV Aqua Ltd Oriental Spring Venture Ltd	10% OWNER	-1.50M	$5.50	-$8.25M	SELL	-45.23%	1.82M	Nov 23	View
Sep 08, 2022	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	600.00K	$3.60	$2.16M	BUY	18.39%	3.86M	Sep 07	View
Sep 08, 2022	Hongbo Lu	—	600.00K	$3.60	$2.16M	BUY	20.12%	3.58M	Sep 07	View
Aug 18, 2022	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC	DIRECTOR	3.69M	$2.42	$8.93M	BUY	∞	762.40K	Aug 16	View
Aug 18, 2022	Carl L Gordon	DIRECTOR	3.69M	$2.42	$8.93M	BUY	∞	762.40K	Aug 16	View
Aug 16, 2022	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	2.62M	$2.66	$6.98M	BUY	410.95%	3.26M	Aug 12 - Aug 16	View
Aug 16, 2022	Hongbo Lu	—	2.62M	$2.66	$6.98M	BUY	734.35%	2.98M	Aug 12 - Aug 16	View
Jun 08, 2022	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	7.66K	$1.47	$11.25K	BUY	∞	7.66K	May 31	View
Jun 08, 2022	Mark J Vignola	CHIEF FINANCIAL OFFICER	7.66K	$1.47	$11.25K	BUY	∞	7.66K	May 31	View
Jun 08, 2022	Senthil Sundaram	CHIEF EXECUTIVE OFFICER	7.66K	$1.47	$11.25K	BUY	∞	7.66K	May 31	View
Feb 09, 2021	Carl Gordon	DIRECTOR	3.79M	$17.00	$8.07M	BUY	∞	2.27M	Feb 09	View
Feb 09, 2021	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd	DIRECTOR	3.79M	$17.00	$8.07M	BUY	∞	2.27M	Feb 09	View
Feb 09, 2021	Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP Vivo Opportunity LLC Vivo Opportunity Fund LP	10% OWNER	2.68M	$17.00	$8.07M	BUY	∞	357.35K	Feb 09	View
Feb 09, 2021	James Flynn DEERFIELD MANAGEMENT COMPANY LP SERIES C DEERFIELD PARTNERS LP Deerfield Mgmt LP	10% OWNER	2.38M	$17.00	$11.30M	BUY	∞	2.38M	Feb 09	View

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Terns Pharmaceuticals Director Hongbo Lu Reported Purchase of 4,124,239 @ Avg Price of $2.57/Share in Form 4 Filing on Tuesday

Charles Gross

3 Stocks Under $2 Insiders Are Aggressively Buying

Lisa Levin

People Also Watch

Axsome Therapeutics Inc

NASDAQ:AXSM

$160.50

Ligand Pharmaceuticals Inc

NASDAQ:LGND

$192.64


Mar 17, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	0.00	$25.67	-$613.44K	SELL-OPTIONS	0.00%	297.30K	Mar 16	View
Feb 18, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	0.00	$21.92	-$503.91K	SELL-OPTIONS	0.00%	297.30K	Feb 17	View
Jan 16, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	150.00K	$20.86	-$2.23M	SELL-OPTIONS	101.84%	297.30K	Jan 14 - Jan 15	View
Jan 06, 2026	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	100.21K	$21.37	-$2.62M	SELL-OPTIONS	212.84%	147.29K	Jan 02 - Jan 05	View
Jan 06, 2026	Emil Kuriakose	CHIEF MEDICAL OFFICER	-1.16K	$38.57	-$44.55K	SELL	-2.24%	50.37K	Jan 02	View
Nov 05, 2025	Jill M Quigley	—	0.00	$13.62	-$214.80K	SELL-OPTIONS	0.00%	0.00	Nov 04	View
Oct 02, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-944.00	$7.85	-$7.41K	SELL	-1.80%	51.52K	Oct 01	View
Jul 03, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-853.00	$4.27	-$3.64K	SELL	-1.60%	52.46K	Jul 01	View
Jun 30, 2025	Andrew Gengos	CHIEF FINANCIAL OFFICER	10.00K	$3.93	$39.28K	BUY	66.67%	25.00K	Jun 27	View
Jun 25, 2025	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	23.31K	$3.87	$90.23K	BUY	98.09%	47.08K	Jun 25	View
Jun 16, 2025	Andrew Gengos	CHIEF FINANCIAL OFFICER	15.00K	$3.81	$57.08K	BUY	∞	15.00K	Jun 13 - Jun 16	View
Apr 02, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-952.00	$2.49	-$2.37K	SELL	-1.75%	53.32K	Apr 01	View
Feb 03, 2025	Melita Sun Jung	CHIEF BUSINESS OFFICER	2.25K	$5.11	$11.50K	BUY	∞	2.25K	Nov 30	View
Feb 03, 2025	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	510.00	$5.11	$2.61K	BUY	2.67%	19.61K	Nov 30	View
Jan 06, 2025	Emil Kuriakose	CHIEF MEDICAL OFFICER	-4.48K	$5.71	-$25.61K	SELL	-7.63%	54.27K	Jan 02	View
Jan 06, 2025	Mark J Vignola	CHIEF FINANCIAL OFFICER	-17.19K	$5.76	-$99.02K	SELL	-18.69%	74.75K	Jan 02 - Jan 06	View
Jan 06, 2025	Jill M Quigley	—	-15.00K	$5.76	-$86.46K	SELL	-100.00%	0.00	Jan 02 - Jan 06	View
Dec 09, 2024	Amy L Burroughs	CHIEF EXECUTIVE OFFICER	15.45K	$7.15	$110.47K	BUY	423.40%	19.10K	Dec 05	View
Sep 17, 2024	Hongbo Lu By: Hongbo Lu	DIRECTOR	476.19K	$10.50	$5.00M	BUY	∞	476.19K	Sep 12	View
Sep 12, 2024	Mark J Vignola	CHIEF FINANCIAL OFFICER	0.00	$8.18	-$56.40K	SELL-OPTIONS	0.00%	91.94K	Sep 10	View
Sep 11, 2024	Jill M Quigley	—	0.00	$5.91	-$140.98K	SELL-OPTIONS	0.00%	15.00K	Sep 09	View
Aug 05, 2024	Jill M Quigley	—	-15.00K	$7.57	-$113.58K	SELL	-50.00%	15.00K	Aug 01 - Aug 02	View
Jul 17, 2024	Carl L Gordon	DIRECTOR	-56.16K	$10.00	-$561.64K	SELL	-6.92%	755.63K	Jul 15 - Jul 16	View
Jul 17, 2024	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC	DIRECTOR	-56.16K	$10.00	-$561.64K	SELL	-6.92%	755.63K	Jul 15 - Jul 16	View
Jul 17, 2024	Jill M Quigley	—	0.00	$5.91	-$120.79K	SELL-OPTIONS	0.00%	30.00K	Jul 15 - Jul 16	View
Jun 04, 2024	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	4.79K	$4.44	$21.27K	BUY	5.50%	91.94K	May 31	View
Jun 04, 2024	Mark J Vignola	CHIEF FINANCIAL OFFICER	4.79K	$4.44	$21.27K	BUY	5.50%	91.94K	May 31	View
Apr 03, 2024	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	-420.66K	$6.65	-$2.80M	SELL	-61.03%	268.57K	Apr 01 - Apr 03	View
Dec 04, 2023	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	743.00	$3.78	$2.81K	BUY	4.21%	18.40K	Nov 30	View
Dec 04, 2023	Mark J Vignola	CHIEF FINANCIAL OFFICER	743.00	$3.78	$2.81K	BUY	4.21%	18.40K	Nov 30	View
Jun 02, 2023	Mark J Vignola	CHIEF FINANCIAL OFFICER	10.00K	$1.41	$14.10K	BUY	130.53%	17.66K	May 31	View
Jun 02, 2023	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	10.00K	$1.41	$14.10K	BUY	130.53%	17.66K	May 31	View
Jun 02, 2023	Senthil Sundaram	CHIEF EXECUTIVE OFFICER	2.11K	$1.41	$2.98K	BUY	27.56%	9.77K	May 31	View
Feb 03, 2023	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	3.00	$1.41	$4.23	BUY	0.04%	7.66K	Nov 30	View
Feb 03, 2023	Mark J Vignola	CHIEF FINANCIAL OFFICER	3.00	$1.41	$4.23	BUY	0.04%	7.66K	Nov 30	View
Feb 03, 2023	Senthil Sundaram	CHIEF EXECUTIVE OFFICER	3.00	$1.41	$4.23	BUY	0.04%	7.66K	Nov 30	View
Dec 28, 2022	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC	DIRECTOR	137.93K	$7.25	$1000.00K	BUY	2.50%	5.65M	Dec 23	View
Dec 28, 2022	Carl L Gordon	DIRECTOR	137.93K	$7.25	$1000.00K	BUY	2.50%	5.65M	Dec 23	View
Dec 23, 2022	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	758.62K	$7.25	$5.50M	BUY	19.64%	4.62M	Dec 23	View
Dec 23, 2022	Hongbo Lu	—	758.62K	$7.25	$5.50M	BUY	21.18%	4.34M	Dec 23	View
Nov 28, 2022	LAV Biosciences Fund V LP Hopewell Resources Holdings Ltd LAV Aqua Ltd Oriental Spring Venture Ltd	10% OWNER	-1.50M	$5.50	-$8.25M	SELL	-45.23%	1.82M	Nov 23	View
Sep 08, 2022	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	600.00K	$3.60	$2.16M	BUY	18.39%	3.86M	Sep 07	View
Sep 08, 2022	Hongbo Lu	—	600.00K	$3.60	$2.16M	BUY	20.12%	3.58M	Sep 07	View
Aug 18, 2022	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC	DIRECTOR	3.69M	$2.42	$8.93M	BUY	∞	762.40K	Aug 16	View
Aug 18, 2022	Carl L Gordon	DIRECTOR	3.69M	$2.42	$8.93M	BUY	∞	762.40K	Aug 16	View
Aug 16, 2022	Vivo Opportunity LLC Vivo Opportunity Fund Holdings LP Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP	10% OWNER	2.62M	$2.66	$6.98M	BUY	410.95%	3.26M	Aug 12 - Aug 16	View
Aug 16, 2022	Hongbo Lu	—	2.62M	$2.66	$6.98M	BUY	734.35%	2.98M	Aug 12 - Aug 16	View
Jun 08, 2022	Seokho Bryan Yoon	COO AND GENERAL COUNSEL	7.66K	$1.47	$11.25K	BUY	∞	7.66K	May 31	View
Jun 08, 2022	Mark J Vignola	CHIEF FINANCIAL OFFICER	7.66K	$1.47	$11.25K	BUY	∞	7.66K	May 31	View
Jun 08, 2022	Senthil Sundaram	CHIEF EXECUTIVE OFFICER	7.66K	$1.47	$11.25K	BUY	∞	7.66K	May 31	View
Feb 09, 2021	Carl Gordon	DIRECTOR	3.79M	$17.00	$8.07M	BUY	∞	2.27M	Feb 09	View
Feb 09, 2021	ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III LP OrbiMed Advisors III Ltd	DIRECTOR	3.79M	$17.00	$8.07M	BUY	∞	2.27M	Feb 09	View
Feb 09, 2021	Vivo Capital VIII LLC Vivo Capital Fund VIII LP Vivo Capital Surplus Fund VIII LP Vivo Opportunity LLC Vivo Opportunity Fund LP	10% OWNER	2.68M	$17.00	$8.07M	BUY	∞	357.35K	Feb 09	View
Feb 09, 2021	James Flynn DEERFIELD MANAGEMENT COMPANY LP SERIES C DEERFIELD PARTNERS LP Deerfield Mgmt LP	10% OWNER	2.38M	$17.00	$11.30M	BUY	∞	2.38M	Feb 09	View